Conference
Immunomodulatory effects of Mepolizumab on group 2 innate lymphoid cells in patients with refractory chronic cough and eosinophilic airways disease (MUCOSA)
Authors
Matsuyama T; Tokunaga Y; Ju X; Fard N; Diab N; Brister D; Hassan W; Wahab M; Kum E; Wattie J
Publisher
European Respiratory Society (ERS)
Publication Date
September 27, 2025
DOI
10.1183/13993003.congress-2025.pa4725
Name of conference
Allergy and immunology